The cluster is dominated by passive/index managers and likely reflects index rebalancing or broad sector rotation into small-cap biotech, not a company-specific catalyst. With Wellington's massive DOUBLED position (+1792% to $29.8M) as the sole active manager signal, watch for next earnings and pipeline updates to see if conviction follows. The historical calibration for this filing type suggests a score-6 has only 34% observed up-move probability at T+20 with average losses large on misses — bias toward caution until a specific catalyst emerges.
Executive Summary
A strong institutional cluster for Trevi Therapeutics (TRVI) in Q3 2025 shows 8 buyers adding $111.4M in aggregate holdings vs. 5 sellers trimming $5.4M, a heavily lopsided net accumulation. The buying is dominated by passive/index funds (Fidelity, Morgan Stanley, Schwab, Wells Fargo, Invesco, BofA) and two asset managers (Wellington, Legal & General), while the selling comes from quant and asset managers (Citadel, RenTech, Point72, Dimensional, Barclays). The magnitude of net buying ($111.4M) relative to a $1.9B market cap is notable (~5.9% of cap), but the active vs. passive split and lack of disclosed catalysts suggest the move was driven primarily by index-related flows and passive rebalancing into a rising biotech stock, not a concentrated active thesis.
Key Financial Metrics
Institutional Positions
Net institutional flow: $106.0M
▲ Buyers (8)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Fidelity | DOUBLED | +795.4% | $30.2M | $28.2M |
| Morgan Stanley | DOUBLED | +320.1% | $39.4M | $33.8M |
| Wellington Management Group | DOUBLED | +1792% | $29.8M | $28.8M |
| BofA | ADD | +67.4% | $16.8M | $10.8M |
| Schwab | DOUBLED | +256.9% | $7.4M | $6.1M |
▼ Sellers (5)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Citadel | NEAR_EXIT | -92.2% | $7.2M | -$6.3M |
| Point72 | TRIM | -45.5% | $9.5M | -$837.2K |
| RenTech | TRIM | -40.1% | $2.7M | $7.0K |
| Dimensional Fund Advisors | TRIM | -67.3% | $695.0K | -$315.8K |
| Barclays | TRIM | -57.9% | $3.0K | $2.0M |
Key Facts
- 8 institutions accumulated $129.2M in aggregate TRVI holdings, adding $111.4M in net new value during Q3 2025
- 5 institutions reduced holdings by $5.4M, with Citadel (NEAR_EXIT, -92.2%) leading the sell-side
- 6 of 8 buyers are mega-passive/index-tracking managers (Fidelity, Morgan Stanley, Schwab, Invesco, BofA, Wells Fargo) — the signal is dominated by passive rebalancing
- Two active asset managers — Wellington (DOUBLED, +1792% to $29.8M) and Legal & General (DOUBLED, +870% to $750K) — also added meaningfully
- The cluster data is from 2025-Q3 (ended Sep 30) and subject to the 45-day 13F filing lag — current positions may differ
Financial Impact
8 buyers added $111.4M in new net value (total holdings $129.2M) while 5 sellers reduced by $5.4M — net institutional accumulation of ~$106M in Q3 2025
Risk Factors
- 13F data is retrospective (quarter-end Sep 30, filed by Nov 14); passive inflows may have already been unwound or reversed in Q4
- The sell-side includes Citadel and Point72 — quant selling may indicate alpha decay or hedging that counters the passive buying thesis
- No specific catalyst (pipeline milestone, approval, partnership) is evident from the cluster data alone to justify forward price appreciation
- Historical calibration shows score-6/7/8 on this filing type have <35% up-move probability at T+20 in this segment, suggesting the passive buying signal has limited predictive power for near-term direction
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-TRVI-2025-Q3 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 11, 2026 16w ago | Institutional Cluster | $13.46 $17.26 | ▲ +28.23% | ▲ +23.84% | — |
Jun 11, 2026 16w ago | Institutional Cluster | $13.46 $17.26 | ▲ +28.23% | ▲ +23.84% | — |
Apr 21, 2026 23w ago | DEFA14A | $14.80 $19.07 | ▲ +28.85% | ▲ +24.07% | — |
Apr 20, 2026 23w ago | Press Release | $14.62 $17.36 | ▲ +18.74% | ▲ +11.84% | — |
Apr 17, 2026 23w ago | 424B5 | $15.40 $18.15 | ▼ −17.82% | ▼ −11.05% | — |
Apr 17, 2026 24w ago | 8-K | $15.23 $17.91 | ▼ −17.60% | ▼ −11.45% | — |
Apr 17, 2026 24w ago | Press Release | $15.23 $17.91 | ▲ +17.60% | ▲ +11.45% | — |
Mar 17, 2026 28w ago | Press Release | $10.69 $13.46 | ▲ +25.91% | ▲ +14.39% | — |
Mar 10, 2026 29w ago | Press Release | $11.94 $13.45 | ▲ +12.65% | ▲ +1.12% | — |
Mar 9, 2026 29w ago | Press Release | $11.70 $13.50 | ▲ +15.38% | ▲ +3.40% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access